Why is SPRY Down Today?

SPRY
$4.82
▼ -4.74% ($-0.23)
Last updated: Sep 11, 2026 8:32 PM ET (1079 min ago)

About ARS Pharmaceuticals, Inc. Common Stock

ARS Pharmaceuticals Inc is a biopharmaceutical company focused on the development of novel, potentially first-in-class product candidate, neffy for the emergency treatment of Type I allergic reactions, including anaphylaxis. neffy is a proprietary composition of epinephrine with an absorption enhanc...

Sector: PHARMACEUTICAL PREPARATIONS
Market Cap: $997.16M
Forward P/E: -5.2
52-Week Range: $4.80 - $13.15
Employees: 167

Overall Confidence: 65%

65% Confident

Based on news, social sentiment, options activity, and sector analysis

SYMPATHY 60% Confidence
🎯 Outperforming sector by 4.2%
This stock is significantly underperforming its PHARMACEUTICAL PREPARATIONS sector peers, suggesting a stock-specific catalyst.

✅ Move Confirmation

MODERATE VOLUME 1.1x average volume

NORMAL - This move is backed by significant volume and appears sustainable.

📍 Sector Context

PHARMACEUTICAL PREPARATIONS sector: -0.5%

SPRY is outperforming its sector by -4.2%. This suggests a stock-specific catalyst.

Market Comparison

SPRY is significantly underperforming the market (-5.6% vs SPY)
S&P 500
SPY
+0.85%
Nasdaq 100
QQQ
+0.87%
SPRY
This Stock
-4.74%
vs S&P 500: -5.59%
vs Nasdaq: -5.61%

📊 What Happens Next?

Probability Analysis

45% chance this move continues in the next 1-3 days

Expected Range

Based on historical patterns and options pricing, SPRY is expected to trade between:
$4.68 - $4.92

Key Level to Watch

$4.58 support
Watch for breakdown below $4.82

🔔 Get SPRY Alerts

We'll notify you when SPRY's trend changes or a new signal fires.

Last updated: Sep 11, 2026 8:32 PM (1079 minutes ago)
Data refreshes every 30 minutes during market hours

Options Market Insight

Bullish
Options Sentiment
0.59
Put/Call Ratio
148.8%
Implied Volatility
Call Volume: 14,404
Put Volume: 8,550
Total: 22,954
Unusual Activity: $7.5 CALL (2,304 vol) $7.5 CALL (2,304 vol)

Historical Context

SPRY has moved more than 3.0% down on 55 occasions in the past year.

50.9%
Continuation Rate
28/55 times continued down
+0.54%
Avg Next Day Change
After similar down moves
Last similar move: Sep 10, 2026 (-3.3%) → Next day: -4.7%

Frequently Asked Questions

Why is SPRY stock down today?

This stock is significantly underperforming its PHARMACEUTICAL PREPARATIONS sector peers, suggesting a stock-specific catalyst.

Is SPRY stock a buy or sell right now?

Based on current analysis, SPRY shows 65% confidence in today's move. Volume is moderate which supports the trend. View full buy/sell analysis →

What is the SPRY stock price target?

SPRY is currently trading at $4.82. Based on today's momentum, the expected short-term range is $4.68 - $4.92. See long-term price prediction →

Will SPRY stock continue falling?

Our analysis shows a 45% probability that SPRY's move continues in the next 1-3 days. Key level to watch: $4.58 (support).

Is SPRY stock oversold or overbought?

SPRY's RSI (Relative Strength Index) is currently at 31.1. This shows bearish momentum - the stock has negative momentum but isn't oversold yet.

What is the momentum for SPRY stock?

SPRY's 10-day momentum indicator is at -1.27. Negative momentum - the stock has mild downward pressure which may continue short-term.

Is SPRY outperforming or underperforming the market?

SPRY (-4.74%) is currently significantly underperforming the market (-5.6% vs SPY). Today, the S&P 500 (SPY) is up 0.85%, and Nasdaq (QQQ) is up 0.87%.

What does MACD indicate for SPRY?

SPRY's MACD (-0.32) is currently below the signal line (-0.26), indicating a bearish trend. This technical signal suggests selling pressure is dominant. The trend strength (ADX: 27.8) is strong.

Is SPRY in an uptrend or downtrend?

Based on moving average analysis, SPRY is in a bearish trend. The price ($4.82) is trading below both the 20-day SMA ($5.7) and 50-day SMA ($6.22). This alignment typically indicates sustained downward pressure.

Check Why Another Stock is Moving

Enter any ticker symbol to see real-time analysis

Popular: AAPL TSLA NVDA MSFT META AMZN GOOGL